Zobrazeno 1 - 10
of 36
pro vyhledávání: '"D. Parshukova"'
Autor:
E. Epimakhova, E. Ermakov, D. Kazantseva, D. Parshukova, E. Dmitrieva, L. Smirnova, S. Ivanova, A. Semke
Publikováno v:
European Psychiatry, Vol 65, Pp S775-S775 (2022)
Introduction DNA-hydrolyzing catalytic IgGs have caspase-dependent cytotoxic effects in autoimmune diseases. Recently, DNA-hydrolyzing IgGs have been discovered in schizophrenia. However, their cytotoxic properties have not been studied. Objectives
Externí odkaz:
https://doaj.org/article/34cd2e2f2f2644f5ad95c6d55dbeed8a
Publikováno v:
European Psychiatry, Vol 65, Pp S777-S777 (2022)
Introduction Alterations in a variety of immune parameters, including abnormal cytokine levels, are known to be found in schizophrenia. These changes can be useful in identifying patients with the most severe immune abnormalities. Objectives To deve
Externí odkaz:
https://doaj.org/article/92b08f88a8174edd8965103a92812b7a
Igg-Dependent Hydrolysis of Myelin Basic Protein of Patients with Different Courses of Schizophrenia
Autor:
Arkadiy V. Semke, Elena G Kornetova, Svetlana A. Ivanova, D. Parshukova, Valentina N. Buneva, L.P. Smirnova
Publikováno v:
Journal of Immunology Research
Journal of Immunology Research, Vol 2020 (2020)
Journal of Immunology Research, Vol 2020 (2020)
The level hydrolysis of myelin basic protein (MBP) by IgG in patients with schizophrenia was studied depending on the clinical features and course of the disease. The patients were grouped according to type of schizophrenia and type of disease course
Publikováno v:
European Neuropsychopharmacology. 53:S347-S348
Autor:
Arkadiy V. Semke, M Khodanovich, Anna V Usova, D. Parshukova, Anna O Pishchelko, Svetlana A. Ivanova, Vasily L. Yarnykh, L.P. Smirnova, Elena G Kornetova
Publikováno v:
Translational psychiatry. 2021. Vol. 11. P. 365 (1-7)
Translational Psychiatry
Translational Psychiatry, Vol 11, Iss 1, Pp 1-7 (2021)
Translational Psychiatry
Translational Psychiatry, Vol 11, Iss 1, Pp 1-7 (2021)
Myelin deficiency is commonly recognized as an important pathological feature of brain tissues in schizophrenia (SZ). In this pilot study, global myelin content abnormalities in white matter (WM) and gray matter (GM) of SZ patients were non-invasivel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19c6ebc1f0b2cccd782bdaf39d6ab3ae
https://vital.lib.tsu.ru/vital/access/manager/Repository/koha:000894694
https://vital.lib.tsu.ru/vital/access/manager/Repository/koha:000894694
Autor:
Alisa R Vasilieva, Evgeny A. Ermakov, L.P. Smirnova, D. Parshukova, Daria V Kazantseva, Elena Dmitrieva
Publikováno v:
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity
Schizophrenia is recognized to be a highly heterogeneous disease at various levels, from genetics to clinical manifestations and treatment sensitivity. This heterogeneity is also reflected in the variety of oxidative stress-related mechanisms contrib
Publikováno v:
International Journal of Molecular Sciences
Volume 21
Issue 19
International Journal of Molecular Sciences, Vol 21, Iss 7238, p 7238 (2020)
Volume 21
Issue 19
International Journal of Molecular Sciences, Vol 21, Iss 7238, p 7238 (2020)
Schizophrenia is known to be accompanied not only with an imbalance in the neurotransmitter systems but also with immune system dysregulation and chronic low-grade inflammation. Extracellular histones and nucleosomes as damage-associated molecular pa
Autor:
Anton J. M. Loonen, Elena G Kornetova, Nikolay A. Bokhan, Anastasiia S Boiko, Irina A. Mednova, Arkadiy V. Semke, D. Parshukova, Svetlana A. Ivanova
Publikováno v:
Metabolites
Volume 10
Issue 10
Metabolites, Vol 10, Iss 410, p 410 (2020)
Metabolites, 10(10):410. MDPI AG
Volume 10
Issue 10
Metabolites, Vol 10, Iss 410, p 410 (2020)
Metabolites, 10(10):410. MDPI AG
The adipokines leptin, adiponectin, tumor necrosis factor-alpha (TNF-&alpha
), and interleukin 6 (IL-6) might be associated with metabolic syndrome (MetS) in patients with schizophrenia. In the present study, we attempted to confirm the results
), and interleukin 6 (IL-6) might be associated with metabolic syndrome (MetS) in patients with schizophrenia. In the present study, we attempted to confirm the results
Autor:
Svetlana A. Ivanova, Larisa Litvinova, Quinn Painter, D. Parshukova, P. A. Zatolokin, Arkadiy V. Semke, Dmitriy N. Atochin, L.P. Smirnova, Nikolai Fattakhov, Daria Skuratovskaia
Publikováno v:
International Journal of Obesity (2005)
Background/objectives The frequency of metabolic syndrome (MetS) is significantly higher in schizophrenia (SCH) patients, when compared to the general populatiotin. The goal of this study was to evaluate whether genetic variants T-786C (rs2070744), G
Publikováno v:
European Neuropsychopharmacology. 53:S633